| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director | Common Stock | 603 | $465,437 | $771.87 | 02 Jan 2026 | Direct |
| REGENERON PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 1,962 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS, INC. | 02 Jan 2026 | 2 | $0 | 4 | Director | 06 Jan 2026, 16:16 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 02 Jan 2025 | 2 | $0 | 4 | Director | 06 Jan 2025, 16:06 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 02 Jan 2024 | 2 | $0 | 4 | Director | 04 Jan 2024, 16:16 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 08 Sep 2023 | 2 | $0 | 4 | Director | 12 Sep 2023, 17:03 |
| REGN | REGENERON PHARMACEUTICALS, INC. | 08 Sep 2023 | 0 | $0 | 3 | Director | 12 Sep 2023, 17:01 |